Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit.
Publication/Presentation Date
2-1-2022
Abstract
INTRODUCTION: Surgical excision remains the most commonly utilized treatment for superficial basal cell carcinoma (sBCC). In the era of cost containment of healthcare, the rising incidence of BCC and the high cost of excision require a continuous search for efficient and cost-effective management.
OBJECTIVE: Examine the feasibility of the diagnosis and treatment of low-risk sBCC in a single visit.
MATERIALS AND METHODS: Retrospective chart review of sBCCs diagnosed and treated in a single visit.
RESULTS: The study identified 151 histologically confirmed sBCCs in 86 patients over a 5-year period, 93 (61.6%) cases of which were diagnosed as low-risk sBCC and treated in a single appointment. The majority of the cases (
CONCLUSIONS: Diagnosis and treatment of sBCC in a single visit is an efficient and cost-effective management option for those who are proficient in identifying low-risk sBCC.
Volume
33
Issue
1
First Page
191
Last Page
194
ISSN
1471-1753
Published In/Presented At
Hattier, G. A., Duffy, R. F., Finkelstein, M. J., Beggs, S. M., & Lee, J. B. (2022). Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit. The Journal of dermatological treatment, 33(1), 191–194. https://doi.org/10.1080/09546634.2020.1737637
Disciplines
Medicine and Health Sciences
PubMedID
32116084
Department(s)
Department of Pathology and Laboratory Medicine
Document Type
Article